Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition-Reference-Cited by-同舟云学术

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition

Published:2013-07-17 Issue:11 Volume:27 Page:1763-1770
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Novak Richard M.,Metch Barbara,Buchbinder Susan,Cabello Robinson,Donastorg Yeycy,Figoroa John-Peter,Adbul-Jauwad Hend,Joseph Patrice,Koenig Ellen,Metzger David,Sobieszycz Magda,Tyndall Mark,Zorilla Carmen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference25 articles.

1. HIV sexual risk behavior over 36 months of follow-up in the worlds first HIV vaccine efficacy trial.;Bartholow;J Acquir Immune Defic Syndr,2005

2. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.;Djomand;J Acquir Immune Defic Syndr,2008

3. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack).;Chiasson;AIDS,1991

4. High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women.;Cohen;J Psychoactive Drugs,1994

5. Syphilis and HIV infection among displaced pregnant women in rural Mozambique.;Cossa;Int J STD AIDS,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis;AIDS and Behavior;2019-09-04

2. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000–2015: Implications for HIV Prevention;Clinical Infectious Diseases;2019-04-12

3. Theory-Based Analysis of Interest in an HIV Vaccine for Reasons Indicative of Risk Compensation Among African American Women;HEALTH EDUC BEHAV;2018

4. Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention;Vaccine;2018-02

5. Sexual Risk and Protective Behaviors Among Reproductive-Aged Women in the United States;Journal of Women's Health;2017-11